+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Neurovascular Devices Market (2022-2027) by Products, Disease Pathology, End User, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 179 Pages
  • April 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5601463
The Global Neurovascular Devices Market is estimated to be USD 65.12 Bn in 2022 and is projected to reach USD 103.45 Bn by 2027, growing at a CAGR of 9.7%.



Market Dynamics


Market dynamics are forces that impact the prices and behaviors of the Global Neurovascular Devices Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations


The Global Neurovascular Devices Market is segmented based on Products, Disease Pathology, End Userand Geography.
  • By Products, the market is classified into Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems, Support Devices, and Neurothrombectomy Devices.
  • By Disease Pathology, the market is classified into Cerebral Aneurysms, Ischemic Strokes, Carotid Artery Stenosis, and Arteriovenous Malformation & Fistulas.
  • By End User, the market is classified into Hospitals & Surgical Centers, Ambulatory Care Centers, and Research Laboratories & Academic Institutes.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles


The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott, Acandis, Asahi Kasei Corp, Balt Group, Cerus Endovascular, Evasc Medical Systems, Gynesonics, Imperative Care, Integer, Johnson & Johnson, Kaneka, Lepu Medical, Medtronic, Merit Medical, Microport, Oxford Endovascular, Penumbra, Perflow, Phenox, Rapid Medical, Secant Group, Sensome, Stryker, Terumo, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant


The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Neurovascular Devices Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The report analyses the Global Neurovascular Devices Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Neurovascular Devices Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Neurovascular Devices Market

What is the estimated value of the Global Neurovascular Devices Market?

The Global Neurovascular Devices Market was estimated to be valued at $65.12 Billion in 2022.

What is the growth rate of the Global Neurovascular Devices Market?

The growth rate of the Global Neurovascular Devices Market is 9.7%, with an estimated value of $103.45 Billion by 2027.

What is the forecasted size of the Global Neurovascular Devices Market?

The Global Neurovascular Devices Market is estimated to be worth $103.45 Billion by 2027.

Who are the key companies in the Global Neurovascular Devices Market?

Key companies in the Global Neurovascular Devices Market include Abbott, Acandis, Asahi Kasei Corp, Balt Group, Cerus Endovascular, Evasc Medical Systems, Gynesonics, Imperative Care and Johnson & Johnson.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Large Target Patient Population
4.1.2 Favorable Reimbursement Scenario
4.1.3 Expansion of Healthcare Infrastructure Across Emerging Markets
4.1.4 Growth in Market Demand for Effective Neurovascular Devices
4.2 Restraints
4.2.1 Dearth of Skilled Neurosurgeons
4.2.2 High Procedural Cost of Neurovascular Surgeries and Related Products
4.3 Opportunities
4.3.1 Increase in the Number of Research Activities in the Field of Neurovascular Therapies
4.3.2 Rise in Demand For Minimally Invasive Neurosurgical Procedures
4.4 Challenges
4.4.1 Stringent Regulations
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Neurovascular Devices Market, By Products
6.1 Introduction
6.2 Aneurysm Coiling & Embolization Devices
6.2.1 Embolic Coils
6.2.2 Bare Detachable Coils
6.2.3 coated Detachable Coils
6.2.4 Flow Diversion Devices
6.2.5 Liquid Embolic Agents
6.3 Cerebral Balloon Angioplasty & Stenting Systems
6.3.1 Carotid Artery Stents
6.3.2 Embolic Protection Devices
6.3.3 Balloon Catheters
6.4 Support Devices
6.4.1 Microcatheters
6.4.2 Guidewires
6.5 Neurothrombectomy Devices
6.5.1 Clot Retrieval Devices
6.5.2 Suction & Aspiration Devices
6.5.3 Snares
7 Global Neurovascular Devices Market, By Disease Pathology
7.1 Introduction
7.2 Cerebral Aneurysms
7.3 Ischemic Strokes
7.4 Carotid Artery Stenosis
7.5 Arteriovenous Malformation & Fistulas
8 Global Neurovascular Devices Market, By End User
8.1 Introduction
8.2 Hospitals & Surgical Centers
8.3 Ambulatory Care Centers
8.4 Research Laboratories & Academic Institutes
9 Americas’ Neurovascular Devices Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe’s Neurovascular Devices Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa’s Neurovascular Devices Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC’s Neurovascular Devices Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 Abbott
14.2 Acandis
14.3 Asahi Kasei Corp
14.4 Balt Group
14.5 Cerus Endovascular
14.6 Evasc Medical Systems
14.7 Gynesonics
14.8 Imperative Care
14.9 Integer
14.10 Johnson & Johnson
14.11 Kaneka
14.12 Lepu Medical
14.13 Medtronic
14.14 Merit Medical
14.15 Microport
14.16 Oxford Endovascular
14.17 Penumbra
14.18 Perflow
14.19 Phenox
14.20 Rapid Medical
14.21 Secant Group
14.22 Sensome
14.23 Stryker
14.24 Terumo
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • Abbott
  • Acandis
  • Asahi Kasei Corp
  • Balt Group
  • Cerus Endovascular
  • Evasc Medical Systems
  • Gynesonics
  • Imperative Care
  • Integer
  • Johnson & Johnson
  • Kaneka
  • Lepu Medical
  • Medtronic
  • Merit Medical
  • Microport
  • Oxford Endovascular
  • Penumbra
  • Perflow
  • Phenox
  • Rapid Medical
  • Secant Group
  • Sensome
  • Stryker
  • Terumo